Cannabidiol, commonly known as CBD, is a substance found in cannabis plants. Unlike THC, CBD does not have psychoactive effects and can provide various therapeutic benefits. But what is the legal rate of CBD in Belgium? In this article, we will present the legislation surrounding CBD in this country as well as the possible uses of this substance.
CBD legislation in Belgium
Just as in many other European countries, Belgian legislation strictly regulates the use of cannabis and its derivatives, including CBD. However, exceptions exist. For example, a 2015 royal decree authorizes the use of Sativex®, a cannabis-based medicine, to treat certain forms of multiple sclerosis. However, it contains both THC and CBD.
Regarding CBD specifically, the law states that it is prohibited to market products containing this substance if its level exceeds 0.2% THC. It is therefore this threshold of 0.2% which constitutes the legal rate of CBD in Belgium. However, you should also know that these products must be obtained from European plants not exceeding 0.2% THC.
The different forms of CBD available in Belgium
CBD can be present in different forms, including:
- CBD oils: they are obtained by cold extraction and can be used as food supplements or applied topically to the skin.
- CBD capsules: more practical for regular intake, they generally contain CBD oil coated in a vegetable capsule.
- CBD e-liquids: they are intended to be vaporized using an electronic cigarette and allow CBD to be inhaled quickly and effectively.
- Creams and balms: these products are generally enriched with CBD and can be applied to the skin to relieve certain skin or joint problems.
Quality assurance and legal rate of CBD
Given the legislation governing CBD in Belgium, it is essential to find out about the origin of the products you wish to purchase. So be careful with quality labels and certificates guaranteeing a THC level below the legal threshold of 0.2%. Do not hesitate to seek advice from experts in specialized CBD stores to be sure that the products offered meet the standards required in Belgium.
Why use CBD?
CBD is said to have numerous therapeutic properties which justify its interest as a food supplement or even in medicines.
Anxiety and depression
CBD could have an anxiolytic and antidepressant effect thanks to its action on receptors in the central nervous system. One study showed that CBD administration significantly reduced anxiety symptoms in patients with generalized social anxiety disorder.
Chronic pain and inflammation
Numerous studies also suggest that CBD has analgesic and anti-inflammatory effects which could be useful in the treatment of chronic pain, such as that associated with fibromyalgia or osteoarthritis.
Epilepsy
The anticonvulsant potential of CBD has also been scientifically proven for several years. In the United States, Epidiolex®, a CBD-based medication, is authorized to treat certain types of severe epilepsy.
The risks of using CBD
Even if CBD does not have psychoactive effects unlike THC, it nevertheless remains a substance derived from cannabis and its consumption must therefore be carried out with caution. Side effects of taking CBD may include:
- Gastrointestinal disorders such as nausea and diarrhea,
- A feeling of fatigue or drowsiness,
- Interactions with other medications.
In order to limit the risks, it is important to follow the advice for use and dosage of CBD-based products as well as to consult a health professional if you wish to integrate CBD into a therapeutic approach.
Towards an evolution of the legislation on the legal rate of CBD in Belgium?
While some neighboring countries have relaxed their legislation regarding cannabis and its derivatives, we could hope that Belgium will take this path in the years to come. Indeed, many associations are campaigning for a review of the legislative framework surrounding CBD in Belgium, in particular in order to facilitate access to this product for patients suffering from serious pathologies for which no effective treatment exists to date.
Among these demands, associations sometimes ask for an increase in the authorized legal level of THC in CBD-based products, arguing that this would allow them to take full advantage of the therapeutic benefits of this substance without necessarily causing unwanted psychoactive effects.
While awaiting a possible change in the legislation, it is nevertheless advisable to continue to scrupulously respect the rules in force and to obtain information from health professionals and the competent authorities before undertaking a treatment based on CBD.
